Results 221 to 230 of about 127,947 (249)

Characterization of [¹⁸F]SMBT-1 binding substrates in Alzheimer's disease and related disorders: A postmortem biochemical and immunohistochemical study. [PDF]

Alzheimers Dement
Abrahamson EE, Kofler JK, Lopez OL, Cohen AD, Gogola A, Aizenstein HJ, Karikari TK, Mufson EJ, Villemagne VL, Ikonomovic MD.   +9 more
europepmc   +1 more source

DIAGnosis using NOvel technology for Subtypes In Stroke (DIAGNOSIS study): performance evaluation protocol. [PDF]

BMJ Neurol Open
Alghamdi I, Almubayyidh M, Gaude E, Jenkins DA, Parry-Jones AR.   +4 more
europepmc   +1 more source

Expresión de GFAP durante el Neurodesarrollo del Pez Cebra (Danio rerio) como Línea Base para el Modelo de Infección Viral por el Virus del Zika

Carol Dayanna Vergara Amaya
openalex   +1 more source

The role of glial fibrillary acidic protein (GFAP) in astrocyte and central nervous system (CNS) dysfunction

Renee Lewis
openalex   +1 more source

The GFAP proteoform puzzle: How to advance GFAP as a fluid biomarker in neurological diseases [PDF]

Journal of Neurochemistry
Glial fibrillary acidic protein (GFAP) is a well-established biomarker of reactive astrogliosis in the central nervous system because of its elevated levels following brain injury and various neurological disorders.
Elly M Hol, Lisa Vermunt, Sanne Abeln
exaly   +4 more sources